Cargando…

Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma

BACKGROUND: The enhancer of zeste 2 (EZH2) gene encodes the histone methyltransferase that is the catalytic component of the polycomb repressive complex-2, which initiates epigenetic silencing of genes. The expression level of EZH2 in hepatocellular carcinoma (HCC) is highly correlated with tumor pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yung-Luen, Su, Kuo-Jung, Hsieh, Yi-Hsien, Lee, Hsiang-Lin, Chen, Tzy-Yen, Hsiao, Pei-Ching, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769270/ https://www.ncbi.nlm.nih.gov/pubmed/24040354 http://dx.doi.org/10.1371/journal.pone.0074870

Ejemplares similares

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
por: Liu, Liang-Chih, et al.
Publicado: (2022)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma
por: Chu, Yin-Hung, et al.
Publicado: (2014)

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression
por: Lau, Hon-Kit, et al.
Publicado: (2016)

Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma
por: Chen, Yao-Li, et al.
Publicado: (2010)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development
por: Wang, Bin, et al.
Publicado: (2017)

Genetic Polymorphisms of lncRNA LINC00673 as Predictors of Hepatocellular Carcinoma Progression in an Elderly Population
por: Yuan, Lan-Ting, et al.
Publicado: (2022)

Downregulation of SHIP2 by Hepatitis B Virus X Promotes the Metastasis and Chemoresistance of Hepatocellular Carcinoma through SKP2
por: Su, Kuo-Jung, et al.
Publicado: (2019)

Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Lin, Chien-Hua, et al.
Publicado: (2020)

CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Licochalcone A Suppresses Migration and Invasion of Human Hepatocellular Carcinoma Cells through Downregulation of MKK4/JNK via NF-κB Mediated Urokinase Plasminogen Activator Expression
por: Tsai, Jen-Pi, et al.
Publicado: (2014)

Association of eNOS and Cav-1 gene polymorphisms with susceptibility risk of large artery atherosclerotic stroke
por: Shyu, Hann-Yeh, et al.
Publicado: (2017)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

TRIM21 Polymorphisms are associated with Susceptibility and Clinical Status of Oral Squamous Cell Carcinoma patients
por: Chuang, Chun-Yi, et al.
Publicado: (2021)

The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
por: Yeh, Chao-Bin, et al.
Publicado: (2013)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

Correction: The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Shiu, Jr-Shiang, et al.
Publicado: (2018)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
por: Ma, Shao-Jun, et al.
Publicado: (2018)

EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
por: Wu, Chen-Shiou, et al.
Publicado: (2023)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Susceptibility to Environmental Factors and the Clinicopathologic Development of Oral Cancer
por: Lin, Chiao-Wen, et al.
Publicado: (2012)

Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
por: Yu, Yung-Luen, et al.
Publicado: (2013)

3′UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma
por: Hua, Kuo-Tai, et al.
Publicado: (2017)

Analysis of MUC6 Genetic Variants on the Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma
por: Lee, Hsiang-Lin, et al.
Publicado: (2022)

Autophagy Inhibition Enhances Apoptosis Induced by Dioscin in Huh7 Cells
por: Hsieh, Ming-Ju, et al.
Publicado: (2012)

Corrigendum to “Autophagy Inhibition Enhances Apoptosis Induced by Dioscin in Huh7 Cells”
por: Hsieh, Ming-Ju, et al.
Publicado: (2017)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
por: Yang, Shun-Fa, et al.
Publicado: (2016)

Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma
por: Ding, Yi-Fang, et al.
Publicado: (2022)

Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2017)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer
por: Fornaro, Lorenzo, et al.
Publicado: (2015)

Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression
por: Yu, Chen-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c00cvfe123mrr114ucjua7vkd4